Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial-Reference-Cited by-同舟云学术

Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Published:2015-01-15 Issue:9 Volume:26 Page:2259-2266
ISSN:1046-6673
Container-title:Journal of the American Society of Nephrology
language:en
Short-container-title:JASN

Author:

Ravani Pietro,Rossi Roberta,Bonanni Alice,Quinn Robert R.,Sica Felice,Bodria Monica,Pasini Andrea,Montini Giovanni,Edefonti Alberto,Belingheri Mirco,De Giovanni Donatella,Barbano Giancarlo,Degl’Innocenti Ludovica,Scolari Francesco,Murer Luisa,Reiser Jochen,Fornoni Alessia,Ghiggeri Gian Marco

Publisher

American Society of Nephrology (ASN)

Subject

Nephrology,General Medicine

Reference44 articles.

1. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines—application to the individual patient

2. Primary Focal Segmental Glomerulosclerosis: Clinical Course and Response to Therapy

3. Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.;McEnery;Pediatr Clin North Am,1982

4. Recurrent focal glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy

5. Primary nephrotic syndrome in children: Clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A randomised, two-arm (1:1 ratio), double blind, placebo controlled phase III trial to assess the efficacy, safety, cost and cost-effectiveness of Rituximab in treating de novo or relapsing NS in patients with MCD/FSGS (TURING);BMC Nephrology;2024-08-07

2. Preventing Relapses in Childhood Nephrotic Syndrome;Kidney International Reports;2024-05

3. Early Rituximab as an Add-On Therapy in Children With the Initial Episode of Nephrotic Syndrome;Kidney International Reports;2024-05

4. Rituximab versus tacrolimus as corticosteroid-sparing therapy for children with steroid-dependent nephrotic syndrome: A systematic review and meta-analysis of randomized and nonrandomized controlled trials;Tzu Chi Medical Journal;2024-04-24

5. Immunosuppressive agents for frequently relapsing/steroid-dependent nephrotic syndrome in children: a systematic review and network meta-analysis;Frontiers in Immunology;2024-02-23